Exceptional molecular organization of canthaxanthin in lipid membranes

• Autorzy: Sujak A.
• Języki publikacji: EN

Abstrakty

EN

Canthaxanthin (β,β-carotene 4,4' dione) used widely as a drug or as a food and cosmetic colorant may have some undesirable effects on human health, caused mainly by the formation of crystals in the macula lutea membranes of the retina of an eye. Experiments show the exceptional molecular organization of canthaxanthin and a strong effect of this pigment on the physical properties of lipid membranes. The most striking difference between canthaxanthin and other macular pigments is that the effects of canthaxanthin at a molecular level are observed at much lower concentration of this pigment with respect to lipid (as low as 0.05 mol%). An analysis of the molecular interactions of canthaxanthin showed molecular mechanisms such as: strong van der Waals interactions between the canthaxanthin molecule and the acyl chains of lipids, restrictions to the segmental molecular motion of lipid molecules, modifications of the surface of the lipid membranes, effect on the membrane thermotropic properties and finally interactions based on the formation of the hydrogen bonds. Such interactions can lead to a destabilization of the membrane and loss of membrane compactness. In the case of the retinal vasculature, it can lead to an increase in the permeability of the retinal capillary walls and the development of retinopathy.

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2012
• Tom: 59
• Numer: 1
• Opis fizyczny: p.31-33,ref.

Twórcy

autor

Sujak A.

• Department of Physics, University of Life Sciences in Lublin, Lublin, Poland

Bibliografia

• Arden GB, Oluwole JO, Polkinghorne P, Bird AC, Barker FM, Norris PG, Hawk JL (1989) Monitoring of patients taking canthaxanthin and β-carotene: an electroetinographic and ophtalmologic survey. Hum Toxicol 8: 439-450. 
• Baker R, Gunther C (2004) The role of carotenoids in consumer choice and the likely benefits from their inclusion into products for human consumption. Trends Food Sci & Technol 15: 484-488.
• Bart JC, MacGillavry CH (1968) The crystal and molecular structure of canthaxanthin. Acta Crystallogr B 24: 1587-1606. 
• Beatty S, Nolan H, Kavanagh O, O'Donovan (2004) Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys 430: 70-76. 
• Bhosale P, Bernstein PS (2007) Vertebrate and invertebrate carotenoid-binding proteins. Arch Biochem Biophys 458: 121-127. 
• Bluhm R, Branch R, Johnston P, Stein R (1990) Aplastic anemia associated with canthaxanthin ingested for 'tanning' purposes. JAMA 264: 1141-1142. 
• Bopp S, el-Hifnawi EL, Laqua H (1989) Canthaxanthin retinopathy and macular pucker. J Fr Ophtalmol 12: 891-896. 
• Boudreault G, Cortin P, Corriveau LA, Rousseau AP, Tardif Y, Malenfant M (1983) Canthaxanthin retinopathy: 1. Clinical study in 51 consumers. Can J Ophthalmol 18: 325-328. 
• Castelli F, Caruso S, Giuffrida N (1999) Different effects of two structurally similar carotenoids, lutein and beta-carotene, on the thermotropic behaviour of phosphatidylcholine liposomes. Calorimetric evidence of their hindered transport through biomembranes. Thermochim Acta 327: 125-131.
• Chew BP, Park JS, Wong MW, Wong TS (1999) A comparison of the anticancer activities of dietary β-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res 19: 1849-1853. 
• Daicker B, Schiedt K, Adnet JJ, Bermond P (1987) Canthaxanthin retinopathy. An investigation by light and electron microscopy and physicochemical analysis. Graefes Arch Clin Exp Ophthalmol 225: 189-197. 
• Goralczyk R, Barker FM, Buser S, Liechti H, Bausch J (2000) Dose dependency of canthaxanthin crystals in monkey retina and spatial distribution of its metabolites. Invest Ophthalmol Vis Sci 41: 1513-1522. 
• Gruszecki WI, Strzalka K (2005) Carotenoids as modulators of lipid membrane physical properties. Biochim Biophys Acta 1740: 108-115. 
• Gruszecki WI (2009) Carotenoids ion lipid membranes In: Physical chemical and Biological Function and Properties. Landrum JT, ed, pp 19-30. Taylor & Francis Group, Boca Raton, London, New York.
• Hennekes R (1986) Peripheral retinal dystrophy following administration of canthaxanthin? Fortschr Ophthalmol 83: 600-601. 
• Kolev VD, Kafalieva DN (1986) Miscibility of beta-carotene and zeaxanthin with dipalmitoylphosphatidylcholine in multilamellar vesicles: a calorimetric and spectroscopic study. Photobiochem Photobiophys 11: 257-267.
• Kostecka-Gugala A, Latowski D, Strzalka K (2003) Thermotropic phase behaviour of alpha-dipalmitoylphosphatidylcholine multibilayers is influenced to various extents by carotenoids containing different structural features-evidence from differential scanning calorimetry. Biochim Biophys Acta 1609: 193-202. 
• Kupisz K, Sujak A, Patyra M, Trebacz K, Gruszecki WI (2008) Can membrane-bound carotenoid pigment zeaxanthin carry out a transmembrane proton transfer? Biochim Biophys Acta 1778: 2334-2340. 
• Li B, Vachali P, Frederick JM, Bernstein PS (2011) Identification of StARD3 as lutein-binding protein in the macula of the primate retina. Biochemistry 50: 2541-2549. 
• Li B, Vachali P, Bernstein PS (2010) Human ocular carotenoid-binding proteins. Photochem Photobiol Sci 9: 1418-1425. 
• Linden A, Bürgi B, Eugster CH (2004) Confirmation of the structures of lutein and zeaxanthin. Helv Chim Acta 87: 1254-1269.
• Lober CW (1985) Canthaxanthin - the 'tanning' pill. J Am Acad Dermatol 13: 660. 
• Macdonald K, Holti G, Marks J (1984) Is there a place for carotene/canthaxanthin in photochemoterapy for psoriasis? Dermatologica 169: 41-46. 
• Mayne ST, Parker RS (1989) Antioxidant activity of dietary canthaxanthin. Nutr Cancer 12: 225-236. 
• McGuinnes R, Beaumont P (1985) Gold dust retinopathy after the ingestion of canthaxanthin to produce skin-bronzing. Med J Aust 143: 622-623. 
• Palozza P, Maggiano N, Calviello G, Lanza P, Piccioni E, Ranelletti FO, Bartoli GM (1998) Canthaxanthin induces apoptosis in human cancer cell lines. Carcinogenesis 19: 373-376. 
• Shafaa MW, Diehl HA, Socaciu C (2007) The solubilisation pattern of lutein, zeaxanthin, canthaxanthin and β-carotene differ characteristically in liposomes, liver microsomes and retinal epithelial cells. Biophys Chem 129: 111-119. 
• Subczynski WK, Wisniewska A, Widomska J (2010) Location of macular xanthophylls in the most vulnerable region sof photoreceptor outer-segment membrane. Archives Biochem Biophys 504: 61-66. 
• Sujak A, Gabrielska J, Grudzinski W, Borc R, Mazurek P, Gruszecki WI (1999) Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. Arch Biochem Biophys 371: 301-307. 
• Sujak A, Gabrielska J, Milanowska J, Mazurek P, Strzalka K, Gruszecki WI (2005) Studies on canthaxanthin in lipid membranes. Biochim Biophys Acta 1712: 17-28. 
• Sujak A, Okulski W, Gruszecki WI (2000) Organisation of xanthophyll pigments lutein and zeaxanthin in lipid membranes formed with dipalmitoylphosphatidylcholine. Biochim Biophys Acta 1509: 255-263. 
• Sujak A, Mazurek P, Gruszecki WI (2002) Xanthophyll pigments lutein and zeaxanthin in lipid multibilayers formed with dimyristoylphosphatidylcholine. J Photochem Photobiol B 68: 39-44. 
• Sujak A, Strzalka K, Gruszecki WI (2007a) Thermotropic phase behaviour of lipid bilayers containing carotenoid pigment canthaxanthin: a differential scanning calorimetry study. Chem Phys Lipids 145: 1-12. 
• Sujak A, Gagos M, Dalla Serra M, Gruszecki WI (2007b) Organization of two-component monomolecular layers formed with dipalmitoylphosphatidylcholine and the carotenoid pigment, canthaxanthin. Mol Membr Biol 24: 431-444. 
• Sujak A (2009) Interactions between canthaxanthin and lipid membranes - possible mechanisms of canthaxanthin toxicity. Cell Mol Biol Lett 14: 395-410. 
• Weber U, Michaelis L, Kern W, Goerz G (1987) Experimental carotenoid retinopathy. II. Functional and morphological alterations of the rabbit retina after canthaxanthin application with small unilamellar phospholipid liposomes. Graefes Arch Clin Exp Ophthalmol 225: 346-450. 
• White GL Jr, Beesley R, Thiese SM, Murdock RT (1988) Retinal crystals and oral tanning agents. Am Fam Physician 37: 125-126. 
• Yeum KJ, Russell RM (2002) Carotenoid bioavailability and Bioconversion. Annu Rev Nutr 22: 483-554. 

Uwagi

PL

Rekord w opracowaniu.